142 related articles for article (PubMed ID: 25706284)
1. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.
Li T; Guo F; Wang Q; Fang H; Li Z; Wang D; Wang H
PLoS One; 2015; 10(2):e0117913. PubMed ID: 25706284
[TBL] [Abstract][Full Text] [Related]
2. A Chimeric Cationic Peptide Composed of Human β-Defensin 3 and Human β-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance.
Yu W; Ning N; Xue Y; Huang Y; Guo F; Li T; Yang B; Luo D; Sun Y; Li Z; Wang J; He Z; Cheng S; Zhang X; Wang H
Front Microbiol; 2021; 12():663151. PubMed ID: 34025617
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Krishnakumari V; Singh S; Nagaraj R
Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
[TBL] [Abstract][Full Text] [Related]
4. Two arginine residues in the COOH-terminal of human β-defensin-3 constitute an essential motif for antimicrobial activity and IL-6 production.
Sakagami-Yasui Y; Shirafuji Y; Yamasaki O; Morizane S; Hamada T; Umemura H; Iwatsuki K
Exp Dermatol; 2017 Nov; 26(11):1026-1032. PubMed ID: 28418601
[TBL] [Abstract][Full Text] [Related]
5. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.
Scudiero O; Galdiero S; Cantisani M; Di Noto R; Vitiello M; Galdiero M; Naclerio G; Cassiman JJ; Pedone C; Castaldo G; Salvatore F
Antimicrob Agents Chemother; 2010 Jun; 54(6):2312-22. PubMed ID: 20308372
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of three beta-defensins from canine testes.
Sang Y; Ortega MT; Blecha F; Prakash O; Melgarejo T
Infect Immun; 2005 May; 73(5):2611-20. PubMed ID: 15845463
[TBL] [Abstract][Full Text] [Related]
7. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains.
Routsias JG; Karagounis P; Parvulesku G; Legakis NJ; Tsakris A
Peptides; 2010 Sep; 31(9):1654-60. PubMed ID: 20600430
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.
Huang LC; Redfern RL; Narayanan S; Reins RY; McDermott AM
Antimicrob Agents Chemother; 2007 Nov; 51(11):3853-60. PubMed ID: 17724155
[TBL] [Abstract][Full Text] [Related]
9. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore EV; Park CH; Quayle AJ; Wiles KR; McCray PB; Ganz T
J Clin Invest; 1998 Apr; 101(8):1633-42. PubMed ID: 9541493
[TBL] [Abstract][Full Text] [Related]
10. A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.
Olli S; Nagaraj R; Motukupally SR
Antimicrob Agents Chemother; 2015 Jan; 59(1):217-25. PubMed ID: 25348533
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.
Yang M; Zhang C; Zhang X; Zhang MZ; Rottinghaus GE; Zhang S
BMC Microbiol; 2016 Sep; 16(1):210. PubMed ID: 27613063
[TBL] [Abstract][Full Text] [Related]
12. Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.
Yang M; Zhang C; Zhang MZ; Zhang S
BMC Microbiol; 2017 Feb; 17(1):43. PubMed ID: 28231771
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.
Harder J; Bartels J; Christophers E; Schroder JM
J Biol Chem; 2001 Feb; 276(8):5707-13. PubMed ID: 11085990
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of synthetic human B defensin-2 against periodontal bacteria.
Mineshiba F; Takashiba S; Mineshiba J; Matsuura K; Kokeguchi S; Murayama Y
J Int Acad Periodontol; 2003 Apr; 5(2):35-40. PubMed ID: 12760504
[TBL] [Abstract][Full Text] [Related]
15. Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.
Chandrababu KB; Ho B; Yang D
Biochemistry; 2009 Jul; 48(26):6052-61. PubMed ID: 19480463
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activities of human beta-defensins against Bacillus species.
Yadava P; Zhang C; Sun J; Hughes JA
Int J Antimicrob Agents; 2006 Aug; 28(2):132-7. PubMed ID: 16797165
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of human β-defensins against lactic acid bacteria.
Wang XF; Tian F; Cao RM; Li J; Wu SM; Guo XK; Chen TX
Nat Prod Res; 2015; 29(22):2164-6. PubMed ID: 25560646
[TBL] [Abstract][Full Text] [Related]
18. Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.
Olli S; Rangaraj N; Nagaraj R
PLoS One; 2013; 8(9):e77031. PubMed ID: 24086767
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial characterization of human beta-defensin 3 derivatives.
Hoover DM; Wu Z; Tucker K; Lu W; Lubkowski J
Antimicrob Agents Chemother; 2003 Sep; 47(9):2804-9. PubMed ID: 12936977
[TBL] [Abstract][Full Text] [Related]
20. Soluble expression of active human beta-defensin-3 in Escherichia coli and its effects on the growth of host cells.
Si LG; Liu XC; Lu YY; Wang GY; Li WM
Chin Med J (Engl); 2007 Apr; 120(8):708-13. PubMed ID: 17517189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
